Elizabeth A. Spencer
0000-0002-6787-1164
Publication & Citation Trends
Publications
0 total
Comparable 12-Week and Superior 24-Week Remission with Risankizumab vs Ustekinumab for Crohn's-Like Disease of the Pouch.
Cited by 0
Semantic Scholar
Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch.
Cited by 3
Semantic Scholar
S1221 Risankizumab Sustains Remission and Improves Anti-TNF-Induced Psoriasiform Dermatitis in Well Controlled Crohn's Disease Patients Switched From Anti-TNF Therapy
Cited by 0
Semantic Scholar
Acute Pouchitis is Common in Pregnant and Postpartum Women OA
Cited by 1
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(62)
Microscopic Colitis
(33)
Immunodeficiency and Autoimmune Disorders
(22)
Eosinophilic Esophagitis
(11)
Pharmaceutical studies and practices
(9)
Affiliations
University of Southern California
Mount Sinai Hospital
Eastern Virginia Medical School
Sinai Hospital
Birmingham and Solihull Mental Health NHS Foundation Trust